Posaconazole Export Market Intelligence: India's 51 Suppliers Shipping to 41 Countries — TransData Nexus 2026

Q: Who are the top posaconazole exporters from India?

The top posaconazole exporters from India are: 1. AET LABORATORIES PRIVATE LIMITED — $105.7M (91.9% market share); 2. HETERO LABS LIMITED — $3.7M (3.2% market share); 3. GLAND PHARMA LTD — $720.7K (0.6% market share); 4. MSN LABORATORIES PRIVATE LIMITED — $307.2K (0.3% market share); 5. RESCUERS LIFE SCIENCES LIMITED — $74.5K (0.1% market share). Together they account for 96.0% of India's total posaconazole export value.

Q: What is the total export value of posaconazole from India?

The total export value of posaconazole from India is $115.1M USD, recorded across 274 shipment transactions from 51 active exporters to 41 destination countries. The average shipment value is $419.9K.

Q: Which countries import posaconazole from India?

India exports posaconazole to 41 countries worldwide. The top importing countries are: UNITED STATES (79.5% share, $91.5M), CYPRUS (8.5% share, $9.7M), CZECH REPUBLIC (4.9% share, $5.7M), AUSTRALIA (2.6% share, $2.9M), UNITED KINGDOM (2.1% share, $2.4M). These five markets account for 97.5% of total export value.

Q: What is the HS code for posaconazole exports from India?

The primary HS code for posaconazole exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of posaconazole exports from India?

The average unit price for posaconazole exports from India is $64.82 USD per unit, with prices ranging from $0.01 to $7069.86 depending on formulation, packaging, and order volume. The total market is valued at $115.1M across 274 shipments.

Q: Which ports handle posaconazole exports from India?

The primary ports for posaconazole exports from India are HYDERABAD AIR (20.4% of shipments), SAHAR AIR (12.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (9.9% of shipments), HYDERABAD ACC (INHYD4) (9.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (4.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of posaconazole?

India is one of the world's leading exporters of posaconazole due to its large base of 51 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports posaconazole to 41 countries, demonstrating 21% global market coverage.

Q: What certifications do Indian posaconazole exporters need?

Indian posaconazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import posaconazole from India?

There are 105 registered buyers importing posaconazole from India, spread across 41 countries. The repeat buyer rate is 51.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top posaconazole supplier from India?

AET LABORATORIES PRIVATE LIMITED is the leading posaconazole exporter from India with a market share of 91.9% and total export value of $105.7M across 121 shipments. The top 5 suppliers together control 96.0% of total export value.

Suresh Sormare

Posaconazole

India Pharmaceutical Trade Intelligence

$115.1M51 Suppliers41 CountriesHS 30049099

ExportsIndia → UNITED STATES79.5%India → CYPRUS8.5%

ImportsBELGIUM → India$367.8K UNITED STATES → India$254.9K

#1 Supplier: AET LABORATORIES

Posaconazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Posaconazole to the World

Between 2022 and 2026, India exported $115.1M worth of posaconazole across 274 verified shipments to 41 countries — covering 21% of world markets in the Advanced Antifungals segment. The largest destination is UNITED STATES (79.5%). AET LABORATORIES PRIVATE LIMITED leads with a 91.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Posaconazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Posaconazole export data snapshot — $115.1M · 51 exporters · 41 countriesTransData Nexus · Indian Customs Data

Top Posaconazole Exporters from India

51 active exporters · Ranked by export value

View all 51 →

Top Posaconazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AET LABORATORIES PRIVATE LIMITED	$105.7M	121	9	91.9%
2	HETERO LABS LIMITED

Top Countries Importing Posaconazole from India

41 destination markets · Ranked by import value

All 41 countries →

Top Countries Importing Posaconazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$91.5M	79.5%
2	CYPRUS	$9.7M	8.5%
3	CZECH REPUBLIC	$5.7M	4.9%
4	AUSTRALIA	$2.9M	2.6%
5	UNITED KINGDOM	$2.4M	2.1%
6	NETHERLANDS	$1.3M	1.1%
7	SAUDI ARABIA	$1.2M	1.0%
8	PERU	$97.0K	0.1%
9	SPAIN	$88.9K	0.1%
10	BANGLADESH	$88.4K	0.1%

UNITED STATES is India's largest posaconazole export destination, absorbing 79.5% of total exports worth $91.5M. The top 5 importing countries — UNITED STATES, CYPRUS, CZECH REPUBLIC, AUSTRALIA, UNITED KINGDOM — together account for 97.5% of India's total posaconazole export value. The remaining 36 destination countries collectively receive the other 2.5%, indicating a focused distribution strategy targeting key markets.

Who Supplies Posaconazole to India?

12 origin countries · Total import value: $1.1M

India imports posaconazole from 12 countries with a combined import value of $1.1M. The largest supplier is BELGIUM ($367.8K, 2 shipments), followed by UNITED STATES and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Posaconazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	BELGIUM	$367.8K	2	32.1%
2	UNITED STATES	$254.9K	53	22.3%
3	UNITED KINGDOM	$252.6K	7	22.1%
4	NETHERLANDS	$160.3K	3	14.0%
5	GERMANY	$85.8K	6	7.5%
6	SLOVENIA	$8.1K	3	0.7%
7	SOUTH AFRICA	$5.1K	2	0.4%
8	AUSTRALIA	$3.7K	2	0.3%
9	CANADA	$3.2K	1	0.3%
10	UNITED ARAB EMIRATES	$2.7K	1	0.2%

Showing top 10 of 12 origin countries

BELGIUM is the largest supplier of posaconazole to India, accounting for 32.1% of total import value. The top 5 origin countries — BELGIUM, UNITED STATES, UNITED KINGDOM, NETHERLANDS, GERMANY — together supply 98.0% of India's posaconazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Posaconazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, posaconazole is marketed under the brand name Noxafil. The FDA approved Noxafil oral suspension (NDA #022003) on September 15, 2006, and the injection formulation (NDA #205596) on March 13, 2014. Additionally, on June 17, 2021, the FDA approved Noxafil for the treatment of invasive aspergillosis in adults and pediatric patients aged 13 years and older, granting orphan drug exclusivity until June 17, 2028.

The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for posaconazole, indicating the presence of generic versions in the market. However, the dominance of AET Laboratories Private Limited in Indian exports suggests that a limited number of Indian manufacturers are supplying posaconazole to the U.S., potentially due to stringent regulatory requirements and market dynamics.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) granted marketing authorization for Noxafil (posaconazole) on October 25, 2005, for treating various invasive fungal infections. Subsequently, on July 25, 2019, the EMA approved Posaconazole Accord, a generic version, for similar indications. (ema.europa.eu)

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and regulation of medicinal products, including posaconazole. Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) standards as outlined by the EMA and MHRA, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Posaconazole is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in treating serious fungal infections. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), reflecting its global acceptance and standardized quality parameters.

4India Regulatory Classification

In India, posaconazole is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for posaconazole, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with regulatory standards and to monitor the export of pharmaceutical products.

5Patent & Exclusivity Status

The primary patents for posaconazole have expired, leading to increased generic competition globally. However, specific formulations or new indications may still be under patent protection, granting exclusivity periods in certain markets. For instance, the FDA granted orphan drug exclusivity to Noxafil for the treatment of invasive aspergillosis until June 17, 2028.

6Recent Industry Developments

In January 2026, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending an extension of the indication for Noxafil gastro-resistant tablets to include treatment of invasive aspergillosis in adults and pediatric patients from 2 years of age weighing more than 40 kg. (ema.europa.eu)

In December 2021, the FDA granted orphan drug designation to posaconazole for the treatment of mucormycosis, highlighting its potential in addressing rare fungal infections.

These developments reflect the evolving regulatory landscape and the ongoing efforts to expand the therapeutic applications of posaconazole.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Posaconazole

Retail & reference prices across 9 markets vs. India FOB export price of $64.82/unit

Global Price Benchmark for Posaconazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$60	USD	According to the FDA's Orange Book, posaconazole is approved for use in the United States.
United Kingdom	$55	GBP	The UK's Medicines and Healthcare products Regulatory Agency (MHRA) lists posaconazole as a licensed medication.
Germany	$55	EUR	The European Medicines Agency (EMA) has authorized posaconazole for use in Germany.
Australia	$60	AUD

Supply Chain Risk Assessment — Posaconazole

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Posaconazole, an antifungal agent, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply, making it a dominant player in this sector. This dependency poses a significant risk, as any disruption in Chinese KSM production can directly impact the availability and cost of Posaconazole APIs.

Recent events have highlighted this vulnerability. In February 2026, the closure of the Strait of Hormuz disrupted the supply of raw materials to Asia's petrochemical industry, leading to production cutbacks and force majeure declarations. Such geopolitical tensions can exacerbate the fragility of supply chains dependent on single-country sourcing for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in the export of Posaconazole from India. The top five exporters account for 96.0% of the total export value, with AET Laboratories Private Limited alone contributing 91.9%. This concentration poses a significant single-source risk; any operational or regulatory issues affecting AET Laboratories could severely disrupt the global supply of Posaconazole.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic manufacturing of critical APIs and reduce reliance on imports. As of November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules used in common antibiotics. While this initiative is a positive step, its impact on diversifying Posaconazole suppliers remains to be seen.

Access Complete Posaconazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 274 transactions across 41 markets.

Request Demo View Pricing

Frequently Asked Questions — Posaconazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top posaconazole exporters from India?

The leading posaconazole exporters from India are AET LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED, GLAND PHARMA LTD, and 3 others. AET LABORATORIES PRIVATE LIMITED leads with 91.9% market share ($105.7M). The top 5 suppliers together control 96.0% of total export value.

What is the total export value of posaconazole from India?

The total export value of posaconazole from India is $115.1M, recorded across 274 shipments from 51 active exporters to 41 countries. The average shipment value is $419.9K.

Which countries import posaconazole from India?

India exports posaconazole to 41 countries. The top importing countries are UNITED STATES (79.5%), CYPRUS (8.5%), CZECH REPUBLIC (4.9%), AUSTRALIA (2.6%), UNITED KINGDOM (2.1%), which together account for 97.5% of total export value.

What is the HS code for posaconazole exports from India?

The primary HS code for posaconazole exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Posaconazole

Posaconazole

Top Posaconazole Exporters from India

Top Countries Importing Posaconazole from India

Who Supplies Posaconazole to India?

Quick Facts

Related Advanced Antifungals

Related Analysis

Need Details?

Regulatory Landscape — Posaconazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Posaconazole

Supply Chain Risk Assessment — Posaconazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Posaconazole Trade Intelligence

Frequently Asked Questions — Posaconazole Exports from India

Who are the top posaconazole exporters from India?

What is the total export value of posaconazole from India?

Which countries import posaconazole from India?

What is the HS code for posaconazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of posaconazole exports from India?

Which ports handle posaconazole exports from India?

Why is India a leading exporter of posaconazole?

What certifications do Indian posaconazole exporters need?

How many buyers import posaconazole from India?

What is the market share of the top posaconazole exporter from India?

Analysis Methodology